Abstract
The mitotic checkpoint complex (MCC) coordinates proper chromosome biorientation on the spindle with ubiquitination activities of CDC20-activated anaphase-promoting complex/cyclosome (APC/C(CDC20)). APC/C(CDC20) and two E2s, UBE2C and UBE2S, catalyze ubiquitination through distinct architectures for linking ubiquitin (UB) to substrates and elongating polyUB chains, respectively. MCC, which contains a second molecule of CDC20, blocks APC/C(CDC20)-UBE2C-dependent ubiquitination of Securin and Cyclins, while differentially determining or inhibiting CDC20 ubiquitination to regulate spindle surveillance, checkpoint activation, and checkpoint termination. Here electron microscopy reveals conformational variation of APC/C(CDC20)-MCC underlying this multifaceted regulation. MCC binds APC/C-bound CDC20 to inhibit substrate access. However, rotation about the CDC20-MCC assembly and conformational variability of APC/C modulate UBE2C-catalyzed ubiquitination of MCC's CDC20 molecule. Access of UBE2C is limiting for subsequent polyubiquitination by UBE2S. We propose that conformational dynamics of APC/C(CDC20)-MCC modulate E2 activation and determine distinctive ubiquitination activities as part of a response mechanism ensuring accurate sister chromatid segregation.
🔬 Techniques
🧬 Organisms
✨ Fluorophores
🧪 Sample Preparation
🔬 Cell Lines
🧪 Reagent Suppliers
💾 Data Repositories
🏛️ Research Organizations (ROR)
Affiliated research institutions:
📋 Methods
Proteins and assays
Proteins used in this study are human except for yeast Hsl1. Recombinant APC/C and its variants contain 100 phosphomimetic mutations ( Qiao et al., 2016 ; Weissmann et al., 2016 ). CDC20, MCC and variants were expressed in Hi5 insect cells and then purified by nickel affinity, cation exchange and size exclusion chromatography. Substrate ubiquitination assays were performed as described, with MCC titrated from 15–250 nM ( Brown et al., 2016 ; Qiao et al., 2016 ). CDC20 ubiquitination assays were adapted from ( Foe et al., 2011 ; Foster and Morgan, 2012 ) to use methyl UB, and extended to include UBE2S with WT UB. To distinguish CDC20 ubiquitination targets, CDC20 A and CDC20 M were N-terminally Myc- and Flag-tagged, respectively, for 2-color western detection by secondary antibodies conjugated with DyLight 488 and Alexa 633, respectively, during a single scan with Typhoon FLA 9500. Hydrolysis of oxyester-linked UBE2C~UB ( Brown et al., 2015 ) was performed three independent times, with 1 μM APC/C or APC/CΔ15, 1 μM CDC20, 5 μM UBE2C~UB, ± 1 μM MCC at 30°C. Reaction products were visualized in Coomassie blue-stained 4–12% NuPAGE gels (Life Technologies). Complex preparation for EM Complexes were purified by sequential affinity pulldowns, followed by specific polishing steps. APC/C CDC20 , and APC/C CDC20 -MCC, or versions lacking APC15, were prepared by either coexpressing APC/C, CDC20, and/or MCC, or by mixing lysates from Hi5 insect cell cultures expressing components independently. Subcomplexes crosslinked to E2 active sites [UBE2C-substrate-UB (FLAG-tagged donor UB mimic), UBE2C-MCC (His 6 -FLAG-tagged BUBR1), UBE2S-UBv-UB (untagged)] were generated largely as described previously ( Brown et al., 2015 ; Brown et al., 2016 ). 2- or 3-way crosslinking between cysteine side-chains was performed through use of BMOE or TMEA (Pierce), respectively. Complexes were initially purified based on affinity tag(s) on APC/C, either a C-terminal Twin-Strep tag on APC4 or sequentially via an N-terminal Twin-Strep tag on APC2 and N-terminal GST-tag on APC16. Complexes were enriched by FLAG-affinity for BUBR1 or a donor UB mimic in some crosslinked complexes, with detailed purification procedures described in Supplemental Information .
Show full methods section
Proteins and assays
Proteins used in this study are human except for yeast Hsl1. Recombinant APC/C and its variants contain 100 phosphomimetic mutations ( Qiao et al., 2016 ; Weissmann et al., 2016 ). CDC20, MCC and variants were expressed in Hi5 insect cells and then purified by nickel affinity, cation exchange and size exclusion chromatography. Substrate ubiquitination assays were performed as described, with MCC titrated from 15–250 nM ( Brown et al., 2016 ; Qiao et al., 2016 ). CDC20 ubiquitination assays were adapted from ( Foe et al., 2011 ; Foster and Morgan, 2012 ) to use methyl UB, and extended to include UBE2S with WT UB. To distinguish CDC20 ubiquitination targets, CDC20 A and CDC20 M were N-terminally Myc- and Flag-tagged, respectively, for 2-color western detection by secondary antibodies conjugated with DyLight 488 and Alexa 633, respectively, during a single scan with Typhoon FLA 9500. Hydrolysis of oxyester-linked UBE2C~UB ( Brown et al., 2015 ) was performed three independent times, with 1 μM APC/C or APC/CΔ15, 1 μM CDC20, 5 μM UBE2C~UB, ± 1 μM MCC at 30°C. Reaction products were visualized in Coomassie blue-stained 4–12% NuPAGE gels (Life Technologies). Complex preparation for EM Complexes were purified by sequential affinity pulldowns, followed by specific polishing steps. APC/C CDC20 , and APC/C CDC20 -MCC, or versions lacking APC15, were prepared by either coexpressing APC/C, CDC20, and/or MCC, or by mixing lysates from Hi5 insect cell cultures expressing components independently. Subcomplexes crosslinked to E2 active sites [UBE2C-substrate-UB (FLAG-tagged donor UB mimic), UBE2C-MCC (His 6 -FLAG-tagged BUBR1), UBE2S-UBv-UB (untagged)] were generated largely as described previously ( Brown et al., 2015 ; Brown et al., 2016 ). 2- or 3-way crosslinking between cysteine side-chains was performed through use of BMOE or TMEA (Pierce), respectively. Complexes were initially purified based on affinity tag(s) on APC/C, either a C-terminal Twin-Strep tag on APC4 or sequentially via an N-terminal Twin-Strep tag on APC2 and N-terminal GST-tag on APC16. Complexes were enriched by FLAG-affinity for BUBR1 or a donor UB mimic in some crosslinked complexes, with detailed purification procedures described in Supplemental Information .
Supplementary Material 1 2 3 4
📊 Figures
Figure 1
Multiple APC/C CDC20 u2013MCC conformations revealed by EM. See also Figure S1 , Tables S1u2013S2 , Movies S1 u2013 S3
(A) Ubiquitination of fluorescent CycB N *, Securin* and CycA*, by APC/C CDC20 , titrating increasing concentrations of either full or core (CDC20 M -BUBR1-MAD2) MCC. (B) CryoEM reconstructions of rep...
Figure 2
u201cSnapshotsu201d of distinct APC/C conformations associated with activation by CDC20 and modulation by MCC. See also Figure S2
(A) Prior apo phosphorylated APC/C ( Zhang et al., 2016 ) showed the APC2 (green)-APC11 (blue) catalytic core as u201cDOWNu201d, blocking the canonical E2 binding site on APC11u2019s RING used by UBE2...
Figure 3
Multiple related elements mediate substrate and MCC association with CDC20 A . See also Figure S3
(A) Scheme of BUBR1 and CDC20 motifs. (B) Close-up views of coactivatoru2013D/CRY-box interactions from crystal structure CDH1u2013D-box ( He et al., 2013 ) and cryo EM map (APC/C CDC20 u039415u2013MC...
Figure 4
APC/C CDC20 u2013MCC OPEN configuration directs UBE2C-catalyzed ubiquitination of CDC20 M . See also Figure S4 (A) Scheme of 2-color western blot distinguishing CDC20 A and CDC20 M in ubiquitination a...
Figure 5
Deletion of APC15 influences APC/C CDC20 u2013MCC conformational regulation and activity with the E2 UBE2C. See also Figure S5 , Table S2 , Table S3
(A) Western blot (anti- APC3, APC10, and APC15) confirming lack of APC15 in recombinant APC/C CDC20 u039415, compared to WT control. (B) Recombinant APC/C CDC20 u039415 recapitulates key endogenous pr...
Figure 6
Elements distinctly mediating MCC interactions with APC/C subunits in CLOSED configuration determine inhibition of CDC20 M ubiquitination. See also Figure S5
(A) APC15 is not absolutely required for APC/C CDC20 -UBE2C to adopt catalytic architecture for CDC20 M ubiquitination. Negative stain EM reconstruction of APC/C CDC20 u039415-UBE2C-MCC core shows tha...
Figure 7
Multiple catalytic and conformational mechanisms contributing to reciprocal regulation of APC/C CDC20 and MCC. See also Figure S6, S7
(A) Left, distinctive catalytic architecture for UBE2S-mediated di-UB synthesis ( Brown et al., 2016 ). Distinct surface of APC11 RING recruits acceptor UB. APC2 C/R domain activates UBE2S catalytic d...
Figure images are served from the NIH/NLM PubMed Central Open Access Subset or Europe PMC; copyright remains with the publishers and authors.
💬 Discussion
0 commentsNo comments yet. Be the first to start a discussion!
Leave a Comment